A small, randomized, controlled clinical trial that was published in 2020 found that there was a statistically significant reduction in intense pain, sharp pain, and cold and itchy sensations in the CBD group when compared to the placebo group. However, a study published in 2023 found no significant difference in neuropathy pain relief effects between cannabis-derived medicines and a placebo
I just thank God every day that we found this medication, because its changed his and my life so much. For more updates about Cleveland, sign up for our Cleveland Magazine Daily newsletter, delivered to your inbox six times a week
Improved tolerability could therefore become an important competitive advantage if these findings translate successfully into clinical studies
FDA-approved GLP-1 peptides such as semaglutide and tirzepatide bind to the GLP-1 receptor, the same receptor a natural gut hormone uses to reduce hunger, slow digestion, and help regulate blood sugar
